Ashland collaborates with University of Mississippi School of Pharmacy to sponsor advanced pharmaceutical tableting course at the Ashland state-of-the-art Research Center; course offers professionals hands-on training in design, processing, manufacturing

Sample article from our Chemicals Industry

July 6, 2023 (press release) –


Registration for limited seating open now


WILMINGTON, Del., July 6, 2023 – Ashland is collaborating with The Pii Center for Pharmaceutical Technology, University of Mississippi School of Pharmacy, to present The Advanced Hands-on Course in Tablet Technology at the Ashland state-of-the-art Research Center in Wilmington, Delaware.  

The course convenes Sunday, September 10, 2023, at 6:00 p.m. ET for registration and reception. Morning lectures from Monday through Thursday provide in-depth training in select areas of oral solid dosage form processing and manufacturing, followed by hands-on practice in afternoon laboratory sessions.

Lectures and labs will be conducted by external speakers from Merck & Co., Inc., Bristol Myers Squibb, Freund Vector Corporation, Medelpharm-Korsch AG, Leistritz Advanced Technologies Corporation, and GEA Group, in addition to lecturers from the University of Mississippi and Ashland.

“This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries who work in research and development, manufacturing, quality control assurance, or regulatory compliance,” said Thomas Durig, senior R&D director, life sciences, Ashland. ”The prerequisite is a fundamental understanding of the science of tablet technology and a desire to gain more knowledge and experience in advanced areas of design and practice.

To register and to see the full schedule, please click here.

About Ashland

Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social, and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. Approximately 3,900 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries. Visit and to learn more.

Trademark, Ashland, or its subsidiaries, registered in various countries.


Media Relations:

Nancy H. Pitts

+1 (412)628-8791

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order chemicals industry coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.